Bank Of Nova Scotia Vertex Pharmaceuticals Inc Transaction History

Bank Of Nova Scotia

$47.4 Billion
Q3 2024

A detailed history of Bank Of Nova Scotia transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of Nova Scotia holds 74,670 shares of VRTX stock, worth $30.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

74,670

Previous 51,367 45.37%

Holding current value

$30.5 Million

Previous $24.1 Million 44.24%

% of portfolio

0.07%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $10.7 Million - $11.8 Million	23,303 Added 45.37%	74,670 $34.7 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $68.6 Million - $84.8 Million	-174,569 Reduced 77.26%	51,367 $24.1 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $66.7 Million - $73 Million	163,589 Added 262.38%	225,936 $94.4 Million
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $1.16 Million - $1.39 Million	3,384 Added 5.74%	62,347 $25.4 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $11.5 Million - $12.3 Million	33,942 Added 135.65%	58,963 $20.5 Million
Q2 2023 Aug 03, 2023	BUY	$314.42 - $351.91 $525,081 - $587,689	1,670 Added 7.15%	25,021 $8.81 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $5.47 Million - $6.24 Million	-19,317 Reduced 45.27%	23,351 $7.36 Million
Q4 2022 Feb 09, 2023	BUY	$285.76 - $321.48 $2.56 Million - $2.87 Million	8,942 Added 26.51%	42,668 $12.3 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $8.57 Million - $9.56 Million	-31,302 Reduced 48.14%	33,726 $9.76 Million
Q2 2022 Aug 08, 2022	BUY	$234.96 - $292.55 $12.7 Million - $15.9 Million	54,195 Added 500.28%	65,028 $18.3 Million
Q2 2022 Aug 05, 2022	SELL	$234.96 - $292.55 $7.67 Million - $9.55 Million	-32,645 Reduced 75.08%	10,833 $3.05 Million
Q1 2022 May 09, 2022	SELL	$221.42 - $260.97 $12.8 Million - $15.1 Million	-57,781 Reduced 57.06%	43,478 $11.3 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $68.5 Million - $86.5 Million	-387,200 Reduced 79.27%	101,259 $22.2 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $81.2 Million - $90.8 Million	447,537 Added 1093.63%	488,459 $88.6 Million
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $7.67 Million - $9.05 Million	40,922 New	40,922 $8.25 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.

Account

Bank Of Nova Scotia Vertex Pharmaceuticals Inc Transaction History